Duration of Ameluz Application in Acral Actinic Keratoses Response

Summary

A phase IV study of a single topical application of ALA for 3 hours or 4 hours to AK on acral sites (hands, feet, arms and legs), and subsequent measurement of clinical efficacy with corresponding PpIX fluorescence imaging.

Timeline

Start

2019-10-30

Primary completion

2024-03-31

Completion

2024-03-31

Outcome

Outcome not reported

Stopped: “Lack of appropriate personnel. Dr Xie abroad on other research, current PI Dr John Frewen not at main centre, no other available PI identified. Study suspended.”

Drugs

Indications